Followers | 105 |
Posts | 20514 |
Boards Moderated | 1 |
Alias Born | 06/30/2012 |
Tuesday, April 28, 2015 7:34:41 PM
They refuse to hype it so more warrant holders will/can exercise and the result will likely be "bad" dilution.
We know Q4 milestone costs will be in the neighborhood of $17-18 million and they HAD $26.1 mil available. That, to me, is the only part of the MD&A I care to see being a good 18 months out (STILL). Just being realistic as PPS will rise as it gets closer to 2017 and their will be more pain in terms of financing(s) before then. Party doesn't even start until December 2015 IMO
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM